 |
Tizanidine HCl |
|---|---|
| Trade Name | Zanaflex |
| Orphan Indication | Spasticity associated with multiple sclerosis and spinal cord injury |
| USA Market Approval | USA |
| USA Designation Date | 1994-01-31 00:00:00 |
| Sponsor | Athena Neurosciences, Inc.;800 Gateway Boulevard;South San Francisco, California, 94080 |
